Tendon and ligament injuries
Additionally, there is a need to monitor dosages to avoid potential hepatotoxicity, particularly when combined with certain herbs that could interact with estrogen levels in the body
Patients taking GLP-1 agonists most commonly complain of gastrointestinal effects, 2 such as unsettled stomach, upset GI tract, variable bowel movements or trouble with elimination, abdominal discomfort, and gastroesophageal discomfort
Q: What should I eat while on Reta
Non-alcoholic steatohepatitis (NASH) is relevant given GLP-1 agonists show hepatic benefits and weight loss ameliorates NASH
See FDA non-inspection-based WLs: Prodose, Inc